At what enterprise value was IMV TECHNOLOGIES acquired in 2010?

During the acquisition of IMV TECHNOLOGIES by SPARRING CAPITAL in 2010, the transaction's Enterprise Value is estimated to be in the range of 50M - 150M EUR.

When was IMV TECHNOLOGIES acquired by SPARRING CAPITAL?

IMV TECHNOLOGIES was acquired by SPARRING CAPITAL in 2010.

What was the revenue of IMV TECHNOLOGIES at the time of the deal?

The revenue of IMV TECHNOLOGIES at the time of the deal is estimated to be in the range of 25M - 50M EUR.

How is the data for the IMV TECHNOLOGIES acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the IMV TECHNOLOGIES deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.eurazeo.com/sites/default/files/presse/20100929_Evolution_du_capital_d-IMV_Technologies1.pdf

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaIMV TECHNOLOGIES

09/2010

IMV TECHNOLOGIES acquired by SPARRING CAPITAL

FRANCE Life Sciences / Pharma & Biotech / R&D Biotech EV 50M - 150M EUR

Context

OFI Private Equity Capital announced the sale of its majority stake in IMV Technologies to Pragma Capital (Renamed Sparring Capital). OFI PE retains a minority stake of 11% by reinvesting EUR5 million alongside the management team led. The transaction concludes a 3-year holding period during which the company accelerated its external growth and opened a new industrial site.

IMV TECHNOLOGIES, which reported an EBITDA margin of in 2009, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

IMV Technologies is the world leader in reproduction biotechnologies for livestock (primarily bovine and porcine). The company designs and manufactures equipment and consumables (plastic straws) for artificial insemination. It holds a dominant position with over 50% global market share in bovine packaging. 85% of its revenue is generated internationally across 120 countries.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2009

2008

Other operations with IMV TECHNOLOGIES

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
01/2021	MONTAGU PRIVATE EQUITY	IMV TECHNOLOGIES	FRANCE	R&D Biotech
11/2014	QUALIUM	IMV TECHNOLOGIES	FRANCE	R&D Biotech

REFERENCES

Valuation range: EV 50M - 150M EUR

Revenue range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of IMV TECHNOLOGIES by SPARRING CAPITAL are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: imv technologies

Acquirer: sparring capital